Currently, Jae-Wan is researching Coronavirus Virus-Like-Particles (VLPs) formation in plant for vaccine development and drug delivery.
This involves producing SARS-Cov-2 VLPs to support development of immune-assay diagnostics and vaccines for COVID-19.
Previously he studied therapeutic protein expression and glycobiology in plants.
Jung J,Choi HY,Huy NX,Park H,Kim HH,Yang MS,Kang SH,Kim DI,Kim NS (2019)Production of recombinant human acid ß-glucosidase with high mannose-type N-glycans in rice gnt1 mutant for potential treatment of Gaucher disease.Protein expression and purificationPublisher's version: 1046-5928
Jung J,Huy NX,Kim HB,Kim NS,Van Giap,Yang MS (2017)Production of recombinant human acid a-glucosidase with high-mannose glycans in gnt1 rice for the treatment of Pompe disease.Journal of biotechnologyPublisher's version: 0168-1656
Jung J,Kim NS,Jang SH,Shin YJ,Yang MS (2016)Production and characterization of recombinant human acid a-glucosidase in transgenic rice cell suspension culture.Journal of biotechnologyPublisher's version: 0168-1656